An Update on BiosimilarsAn Update on Biosimilars

Biosimilars to adalimumab, etanercept, and infliximab measure up safety and efficacy-wise for rheumatology patients inadequately responsive to methotrexate. Medscape Rheumatology
Source: Medscape Rheumatology Headlines - Category: Rheumatology Tags: Rheumatology Commentary Source Type: news